Back
Procter & Gamble 10K Form
Buy
53
PG
Procter & Gamble
Last Price:
154.47
Seasonality Move:
5.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-04-20 | 10Q | PG/Procter & Gamble Quarterly |
2021-01-20 | 10Q | PG/Procter & Gamble Quarterly |
2020-10-20 | 10Q | PG/Procter & Gamble Quarterly |
2020-08-10 | 10K | PG/Procter & Gamble Annual |
2020-08-07 | 10K | PG/Procter & Gamble Annual |
2020-08-06 | 10K | PG/Procter & Gamble Annual |
Receive PG News And Ratings
See the #1 stock for the next 7 days that we like better than PG
PG Financial Statistics
Sales & Book Value
Annual Sales: | $82.01B |
---|---|
Cash Flow: | $4.61B |
Price / Cash Flow: | 27.84 |
Annual Sales: | $19.46 |
Price / Book: | 7.93 |
Profitability
EPS (TTM): | 5.90000 |
---|---|
Net Income (TTM): | $14.65B |
Gross Margin: | $39.25B |
Return on Equity: | 32.87% |
Return on Assets: | 12.38% |
Procter & Gamble Earnings Forecast
Key Procter & Gamble Financial Ratios
- The Gross Profit Margin over the past 40 years for PG is 47.86%.
- The Selling, General & Administrative Expenses for PG have been equal to 25.74% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 5.16% of Operating Income.
- The Net Earning history of PG is 17.87% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 28 years.
Procter & Gamble Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Household & Personal Products |
Sector: | Consumer Defensive |
Current Symbol: | PG |
CUSIP: | 742718 |
Website: | pginvestor.com |
Debt
Debt-to-Equity Ratio: | 0.74 |
---|---|
Current Ratio: | 0.63 |
Quick Ratio: | 0.38 |
Price-to-Earnings
Trailing P/E Ratio: | 26.19 |
---|---|
Forward P/E Ratio: | 22.4 |
PG Technical Analysis vs Fundamental Analysis
Buy
53
Procter & Gamble (PG)
is a Buy
Is Procter & Gamble a Buy or a Sell?
-
Procter & Gamble stock is rated a Buy
The current Procter & Gamble [PG] share price is $154.51. The Score for PG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.